AS Treatment: Anti-IL17
Early Tx Response Predicts 2-Year AS Outcomes Improvement in first 3 months on secukinumab tied to better long-term response medpagetoday.com Secukinumab Reduces Fatigue in Patients With Ankylosing Spondylitis By Jill…
The 9 Muses are daughters of Zeus and Mnemosyne, Greek goddesses personifying the inspiration for the sciences and the arts.
My highly opinionated news-blog draws inspiration from both the science and the art of Rheumatology.
AS & Th17/IL17
Mechanistic rationales for targeting interleukin-17A in spondyloarthritis The term spondyloarthritis (SpA) is used to describe a group of inflammatory autoimmune diseases, including ankylosing spondylitis and psoriatic arthritis, with common genetic…
AS Treatment: Anti-TNF
In patients with SpA unresponsive to NSAIDs, etanercept yielded improvements to 104 weeks In patients with early, active non-radiographic… healio.com A case of glass half-full or half-empty, depending on how…
AS Treatment: NSAID
Efficacy of long-term nonsteroidal antiinflammatory drug treatment on magnetic resonance imaging-determined bone marrow oedema in early, active axial spondyloarthritis patients To assess the efficacy of long-term treatment with nonsteroidal antiinflammatory…
AS Treatment: Exercise
A Prescription for Exercise With all the current therapies for ankylosing spondylitis (AS)—anti-inflammatory medications, biologics, dietary modifications, and even surgery in some cases— the consensus among most is that exercise…
AS: Treat-to-Target
International Guidelines Say Use Treat-to-Target for SpA, PsA The 2017 guidelines for treating SpA and PsA incorporate new data strengthening support for treating to target, but one expert worries they…
AS: Treatment Guidelines
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis To update and integrate the recommendations for ankylosing spondylitis and the recommendations for the use of tumour necrosis factor inhibitors…
AS: Window of Opportunity
The window of opportunity: a relevant concept for axial spondyloarthritis The window of opportunity is a concept critical to rheumatoid arthritis treatment. Early treatment… arthritis-research.biomedcentral.com The window of opportunity is…
AS: Detecting Disease Activity
Plasma, urine and ligament tissue metabolite profiling reveals potential biomarkers of ankylosing spondylitis using NMR-based metabolic profiles Ankylosing spondylitis (AS) is an autoimmune rheumatic disease mostly affecting the axial skeleton.…
AS: Missed/Mis-Diagnosis
Radiographic Evaluation of Sacroiliac Joints in Axial Spondyloarthritis — Still Worth Performing? Radiographic evaluation of sacroiliac (SI) joints… jrheum.org The yield of a positive MRI of the spine as imaging…
- Go to the previous page
- 1
- …
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- …
- 108
- Go to the next page